Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells - Nature
Briefly

This collaborative study showcases the advancements in cancer research achieved through joint efforts across various institutions, highlighting the importance of teamwork in scientific breakthroughs.
The research emphasizes innovative treatment strategies that demonstrate enhanced efficacy in targeted therapies, signifying a shift towards more personalized cancer treatment approaches.
Through extensive clinical trials, the findings reveal significant improvements in patient outcomes, supporting the need for ongoing research and development in the oncology sector.
The authors advocate for greater collaboration and knowledge sharing in the medical community to accelerate the pace of innovation in cancer therapies.
Read at Nature
[
]
[
|
]